| SpectraBase Spectrum ID |
GViLjmrikRE |
| Name |
A-CHMINACA |
| Classification |
Indazole cannabinoid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
391.262362694 u |
| Formula |
C25H33N3O |
| InChI |
InChI=1S/C25H33N3O/c29-24(26-25-13-18-10-19(14-25)12-20(11-18)15-25)23-21-8-4-5-9-22(21)28(27-23)16-17-6-2-1-3-7-17/h4-5,8-9,17-20H,1-3,6-7,10-16H2,(H,26,29)/t18-,19+,20-,25- |
| InChIKey |
ACFKPINHOINOFB-UWIHHVNISA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
391.559 g/mol |
| Nominal Mass |
391 u |
| Quality |
965 |
| Retention Index |
3224 |
| SMILES |
C12(NC(C=3C=4C(N(N3)CC3CCCCC3)=CC=CC4)=O)C[C@]3(C[C@@](C2)(C[C@@](C1)(C3)[H])[H])[H] |
| SPLASH |
splash10-0007-6943000000-cd140469f7d27f5789e9 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
ACHMINACA
N-(Adamantan-1-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_030598 |
